Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

Top Keywords

GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

MAKING NEW YORK CITY A BIO-MECCA

9/18/2008

- Lenzie Harcum, Vice President of Business Development in Biosciences at the New York City Economic Development Corporation, and Bill Fair, Managing Director at Alexandria Real Estate Equities

New York City boasts more than a dozen world-class research institutions and has been home to Wall Street since Colonial times. It provides an aggregation of scientific, clinical, and entrepreneurial talent, along with investment capital and a range of professional services focused on bioscience. New York City, which is home to 125 life science companies, also offers access to the East Coast pharmaceutical corridor.

Yet, New York is not mentioned in the same breath as San Francisco and Boston, long known for their pioneering biotech efforts and the presence of significant life science communities. How come?

During this week's podcast, Lenzie Harcum from the New York City Economic Development Corporation, and Bill Fair from Alexandria Real Estate Equities, explain why the city is not generally viewed as a major life science cluster. They also discuss initiatives the city is taking to raise awareness about New York's bioscience infrastructure and capabilities. In addition, Harcum and Fair describe the ongoing development of the East River Science Park and the Brooklyn Army Terminal as advanced biotech research centers.

Click the "LISTEN" button above or below for this week's podcast.

Lenzie Harcum is Vice President of Business Development in Biosciences at the New York City Economic Development Corporation.

Bill Fair is Managing Director at Alexandria Real Estate Equities.

Subscription center

GEN MAGAZINE
	Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization. Subscribe

e-NEWSLETTERS
Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
GEN Daily News Highlights - provides succinct and timely biotech news on the entire biotech field. GEN News Highlights of the Week - showcases the week's top biotech news. GEN Table of Contents (TOC) Alert - This alert provides a sneak peak at the latest issue of GEN. GEN Tech Focus - is published monthly to provide the latest advances in biotech's hottest topics. GEN Biotech Events - a weekly newsletter featuring webinars, meetings, and conferences. GEN New Products Watch - a monthly summary of products and services by tool providers. New product information and special offers from select biotech suppliers.
	All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format


	Sign Up